logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
C

CPT-Pharmacometrics & Systems Pharmacology

IF3
Papers123
Citations
Journal Papers 123
Publication Date
delete
Aflibercept 8 mg: From Ocular Clearance to Pharmacodynamic Duration
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-10-11
delete0
deleteOAAI
deleteDaniele Veritti; Valentina Sarao; Paolo Lanzetta
deleteShare
deleteSave
Causal Exposure‐Response Analysis: Estimands, Time‐Varying Confounding, and the Parametric g‐Formula
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-10-09
delete0
PREAI
deleteNathan Braniff
deleteShare
deleteSave
Integrating a Tumor Size‐Overall Survival Model Into a Spatial Quantitative Systems Pharmacology Framework for Antibody‐Drug Conjugates in Non‐Small Cell Lung Cancer
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-10-09
delete0
PREAI
deleteMehdi Nikfar; Richard Franzese; Herbert Struemper; Brett Howell; Murad Melhem
deleteShare
deleteSave
Dynamic Prediction of Clinical Endpoints in Survival Analysis With Machine and Deep Learning: A Systematic Review and Regulatory Perspective
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-10-08
delete0
PREAI
deleteXinyi Liu; Shuai Shao; Dorothee Semiond; Malidi Ahamadi
deleteShare
deleteSave
Application of an Open-Source Modular Framework for Pharmacokinetic, Pharmacodynamic, and Safety Simulations to Anti-Tuberculosis Drugs
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-10-07
delete0
deleteOAAI
deleteMarco Siccardi; Nina Nauwelaerts; Raphaëlle Lesage; Diane Lefaudeux; Vanessa Baier; Venetia Karamitsou; Cleo Demeester; Miao-Chan Huang; Alexander Kulesza; Stephan Schaller
deleteShare
deleteSave
Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-30
delete0
deleteOAAI
deleteJohn D. Clements; Inmaculada C. Sorribes; Josh Kaullen; Christine Neumar; Adekemi Taylor; Mun Sang Yue; Xi Chen; Herbert Struemper; Geraldine Ferron-Brady
deleteShare
deleteSave
Population Pharmacokinetics of Dolutegravir in Plasma and Cerebrospinal Fluid in Adults Living With HIV
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-30
delete0
deleteOAAI
deleteMohammed W. Ali; Sam Nightingale; Tracy Kellermann; John Joska; Alan Winston; Saye Khoo; Joseph F. Standing; Eric H. Decloedt; Ahmed A. Abulfathi
deleteShare
deleteSave
Development, Early Verification and Application of a North American Pediatric PBPK Model, Comparison With the North European Pediatric Population
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-25
delete0
deleteOAAI
deleteTrevor N. Johnson; Fiskani Kondowe; Joyce van der Heijden; Saskia N. de Wildt; Iain Gardner; Karen Rowland Yeo
deleteShare
deleteSave
PMxAgent: An Agentic Platform for Pharmacometrics
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-25
delete0
deleteOAAI
deletePeter Bloomingdale; Antari Khot
deleteShare
deleteSave
A Practical Tutorial on Physics-Informed Networks for Pharmacometrics and Quantitative Systems Pharmacology
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-23
delete0
deleteOAAI
deleteNazanin Ahmadi Daryakenari; Mohammad Kohandel
deleteShare
deleteSave
Population Pharmacokinetics of Topical Timolol Maleate Gel in Healthy Volunteers and Infants With Superficial Infantile Hemangioma
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-21
delete0
deleteOAAI
deleteLi Li; Yanming Li; Fan Hu; Deming Wang; Ning Sun; Qingheng Meng; Qin Yu; Ling Xu; Libo Zhao; Lin Ma
deleteShare
deleteSave
A Quantitative Systems Pharmacology Model of Human Leucine Metabolism
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-18
delete0
deleteOAAI
deleteJ. Cody Herron; Anna Sher; Yingbo Ma; Elisabeth Roesch; Sebastian Miculța-Câmpeanu; Christopher Rackauckas; Kevin J. Filipski; Rachel Roth Flach; Theodore R. Rieger; Cynthia J. Musante; Richard Allen
deleteShare
deleteSave
Pharmaceutical Industry Perspectives on Exposure-Response Confounding in Large Molecule Therapeutics: Results From an IQ Consortium Survey
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-16
delete0
deleteOAAI
deleteEngie Salama; Manisha Lamba; Sihem Ait-Oudhia; Ellen Wang; Dorothee Semiond; Zhang Li; Tao Long; Satyendra Suryawanshi; Leticia Arrington; Wei Gao; Xiaowen Guan; Hugh Giovinazzo; Dale Miles; David C. Turner
deleteShare
deleteSave
Transporter-Drive Interstitial Tissue Exposure and Pharmacodynamic Response of Meropenem in Sepsis: A Mechanistic PBPK Modeling Study
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-16
delete0
deleteOAAI
deleteLaura Ben Olivo; Jessica Luisa Silva de Lemos; Vinicius Jardim Rodrigues; Bibiana Verlindo de Araújo
deleteShare
deleteSave
Net Renal Drug Secretion Critically Requires Significant Contribution of Basal Uptake Transporters: Perspective From Mechanistic Kidney Model Simulation and Integration of Clinical and In Vitro Data
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-16
delete0
deleteOAAI
deleteToshiaki Tsuchitani; Masatoshi Tomi; Yuichi Sugiyama
deleteShare
deleteSave
Integrating CRRT as a Virtual Organ Into Physiologically Based Pharmacokinetic Modeling to Optimize Antimicrobial Dosing in Septic Patients
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-16
delete0
deleteOAAI
deleteYuanming Xing; Yijing Zhang; Chuqi Bai; Yulan Qiu; Chuhui Wang; Lei Chen; Taotao Wang; Jiaojiao Chen
deleteShare
deleteSave
Development of Integrated Parent–Metabolite Pharmacokinetic Model With Apparent Presystemic Metabolism to Characterize the Disposition of Alverine
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-16
delete0
deleteOAAI
deleteAra Cho; Hyeon-Cheol Jeong; MinJu Kim; Inkyung Cho; Hyeon-Jeong Na; Kyong-Cheol Ko; Yoon-Jee Chae; Kyeong-Ryoon Lee
deleteShare
deleteSave
Model-Based Tacrolimus Dosing Using the Population Pharmacokinetic Analysis Under the Nirmatrelvir/Ritonavir Therapy
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-16
delete0
deleteOAAI
deleteKotaro Itohara; Yoshiki Katada; Takahiro Hatayama; Toshiaki Igarashi; Jiro Ogura; Tomoki Fukushima; Shingo Yamazaki; Masato Homma; Takashi Niwa; Yoshiaki Kato; Nanae Yamamoto; Hideyuki Terazono; Hideo Shiohira; Tomohiro Terada; Ikuko Yano
deleteShare
deleteSave
Semi-Mechanistic Modeling of S-531011, a Humanized Anti-CCR8 Monoclonal Antibody, for Prediction of CCR8 Receptor Occupancy in Human Tumor Tissues
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-16
delete0
deleteOAAI
deleteDaichi Yamaguchi; Wataru Nogami; Yudai Sonoda; Hitomi Morihara; Takayuki Katsube
deleteShare
deleteSave
Adjoint and Unrolled Automatic Differentiation for Laplace-Approximated Likelihoods in Population PK and PK/PD Models
deleteCPT-Pharmacometrics & Systems Pharmacology
IF3
delete2026-09-16
delete0
deleteOAAI
deleteGuido H. Jajamovich; William Holmes; Chih-Wei Lin; Khamir Mehta
deleteShare
deleteSave